Clinical Trial

Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment

Study acronym: Cohort-NHS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Disease or general study area: Uncomplicated rhegmatogenous retinal detachment (RRD) and risk of proliferative vittroretinopathy (PVR) Purpose and nature of the study: 1. Characterise the cytokine profile of vitreous fluid in uncomplicated RRD. 2. Develop a risk model to predict development of PVR after retinal detachment surgery using imaging and molecular biomarkers. 3. To develop deep learning/artificial intelligence (AI) models for PVR detection in retinal detachment. Inclusion criteria: 50 adult ( ≥18 years) patients with uncomplicated rhegmatogenous retinal detachments without PVR. What participating will involve: Pre- and post-operative assessments and intervention will follow standard of care for patients with rhegmatogenous retinal detachments. Additional intervention will include non-invasive imaging of anterior chamber flare, vitreous, wide-field retina, macula optical coherence tomography (OCT) and macula OCT-angiography (OCT-A) as well as, seeking participant's consent on collecting their vitreous fluid at time of their surgery for cytokine analysis.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09-01 -> 2027-01-27 2026-05-07
minor Completion pushed: 2026-09-01 -> 2027-01-27 2026-05-07
Trial Details
NCT Number NCT07386678
Lead Sponsor University College, London
Conditions Retinal Detachment Rhegmatogenous, Proliferative Vitreoretinopathy, Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Enrollment 50 participants
Start Date 2026-04-27
Primary Completion 2027-01-27 (estimated)
Study Completion 2027-01-27 (estimated)
Updated on ClinicalTrials.gov 2026-05-06